Ceria Therapeutics Inc.

Timeline

1. Feb 17, 2025 Grant Government grant — SBIR: $1.03M (annual award, as published), announced Feb 17, 2025. Agency: NIH/NIDDK. Source: government award database. source ↗

Funding

Last 2 years.

• Feb 17, 2025 Government grant — SBIR: $1.03M (annual award, as published), announced Feb 17, 2025. Agency: NIH/NIDDK. Source: government award database. source ↗

NIH awards 5

Annual award amounts. Total $3.6M.

• Aug 30, 2024 NIH award 5R44HL162137-03 FY2024: $1,216,721 awarded for that fiscal year; activity R44 (SBIR); PI JACKSON, DAVID; recipient as written: CERIA THERAPEUTICS, INC., Tucson, AZ. Targeting inflammation and oxidative stre source ↗
• Jan 15, 2024 NIH award 1R44DK136463-01A1 FY2024: $1,006,408 awarded for that fiscal year; activity R44 (SBIR); PI JACKSON, DAVID; recipient as written: CERIA THERAPEUTICS, INC., Tucson, AZ. A Novel Anti-inflammatoryand Anti-oxida source ↗
• Sep 15, 2023 NIH award 2R44HL162137-02 FY2023: $807,362 awarded for that fiscal year; activity R44 (SBIR); PI JACKSON, DAVID; recipient as written: CERIA THERAPEUTICS, INC., Tucson, AZ. Targeting inflammation and oxidative stress source ↗
• Sep 16, 2022 NIH award 1R43DK133040-01A1 FY2022: $299,249 awarded for that fiscal year; activity R43 (SBIR); PI JACKSON, DAVID; recipient as written: CERIA THERAPEUTICS, INC., Tucson, AZ. A Novel Anti-inflammatory and Anti-oxidan source ↗
• Mar 21, 2022 NIH award 1R43HL162137-01 FY2022: $299,271 awarded for that fiscal year; activity R43 (SBIR); PI JACKSON, DAVID; recipient as written: CERIA THERAPEUTICS, INC., Tucson, AZ. Targeting inflammation and oxidative stress source ↗